Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123165) titled 'The Efficacy and Safety of Huaiqihuang Granules in the Adjuvant Treatment of Autoimmune Uveitis in Children' on April 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Chengdu City Women and Children's Central Hospital
Condition:
Autoimmune Uveitis in Children
Intervention:
Control Group:Receive hormone therapy as part of the conventional treatment regimen
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Control Group:35;Combination Group:35;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn...